Friday, June 26, 2009 2:29:38 PM
Recent SWTX News
- SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology • GlobeNewswire Inc. • 10/21/2025 06:00:13 AM
- European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors • GlobeNewswire Inc. • 08/18/2025 01:10:52 PM
- European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN • GlobeNewswire Inc. • 07/18/2025 03:30:23 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/11/2025 10:00:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:26:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:23:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:22:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:21:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:19:20 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/01/2025 08:11:31 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 07/01/2025 08:03:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 12:38:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/26/2025 08:45:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/16/2025 10:16:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 10:15:03 AM
- SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN • GlobeNewswire Inc. • 05/23/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 09:13:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 08:17:26 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of SpringWorks Therapeutics, Inc. • PR Newswire (US) • 04/28/2025 09:33:00 PM

